How have CRJTF shares performed in 2024?

Crossject Société Anonyme's stock was trading at $3.25 at the beginning of the year. Since then, CRJTF stock has increased by 0.0% and is now trading at $3.25. View the best growth stocks for 2024 here .

When did Crossject Société Anonyme's stock split?

Shares of Crossject Société Anonyme split on the morning of Monday, January 3rd 2022. The 2-1 split was announced on Monday, January 3rd 2022. The newly minted shares were issued to shareholders after the market closes on Monday, January 3rd 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How do I buy shares of Crossject Société Anonyme?

Shares of CRJTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTC:CRJTF

Crossject Société Anonyme (CRJTF) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free CRJTF Stock Alerts

$3.25

0.00 (0.00%)

(As of 07/27/2022)

Compare

Today's Range: $3.25
▼
$3.25
50-Day Range: $3.25
▼
$3.25
52-Week Range: $3.25
▼
$3.25

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Crossject Société Anonyme alerts:

Ad Gold Safe Exchange

Trump’s “Tax Free” Retirement Strategy

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…

About Crossject Société Anonyme

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.

CRJTF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CRJTF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive CRJTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crossject Société Anonyme and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTC
Sector: Medical
Industry: Medical Specialties
Sub-Industry: N/A
Current Symbol: OTC:CRJTF
CUSIP: N/A
CIK: N/A
Web: www.crossject.com
Phone: 33.3.80.54.98.50
Fax: N/A
Employees: 94
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Patrick Alexandre
Co-Founder, CEO & Chairman of the Exec. Board
Dr. Isabelle Liebschütz
Chief Quality & Regulatory Officer and Member of Exec. Board
Mr. Henri de Parseval
COO of Engineering & Industry and Member of Exec. Board
Mr. Olivier Giré
COO of Specialty Pharma & Member of Exec. Board

Key Competitors

View All Competitors

CRJTF Stock Analysis - Frequently Asked Questions

How have CRJTF shares performed in 2024?: Crossject Société Anonyme's stock was trading at $3.25 at the beginning of the year. Since then, CRJTF stock has increased by 0.0% and is now trading at $3.25.
View the best growth stocks for 2024 here.
When did Crossject Société Anonyme's stock split?: Shares of Crossject Société Anonyme split on the morning of Monday, January 3rd 2022. The 2-1 split was announced on Monday, January 3rd 2022. The newly minted shares were issued to shareholders after the market closes on Monday, January 3rd 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.
How do I buy shares of Crossject Société Anonyme?: Shares of CRJTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTC:CRJTF) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial